NEW
YORK, Jan. 24, 2025 /PRNewswire/ -- Baird
Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or
the "Company"), a leader in minimally invasive Microwave Ablation
(MWA) technology, is pleased to announce its participation in the
2025 North American Society for Interventional Thyroidology (NASIT)
Conference, taking place January 31 –
February 1, 2025, in Washington, D.C.
The NASIT Conference is a premier forum for education, research,
and collaboration in thyroid interventions, and Baird Medical is
honored to participate in this key industry event. The Company's
invitation highlights its growing prominence in the field of
microwave ablation while offering a valuable opportunity to engage
with global experts, industry leaders, and potential partners.
As a returning participant, Baird Medical is excited to
contribute to discussions on the latest advancements in MWA
technology and to collaborate with leading experts in
interventional thyroidology. The Company also sees this as an
opportunity to gain deeper insights into industry trends, optimize
its strategic initiatives, and continue driving innovation and
growth in global healthcare.
During the conference, Dr. Emad
Kandil, Professor and Ellis Hanna Chair in Surgery at
Tulane University School of Medicine,
will present at the Product Theater, building on his recent
milestone of completing 100 MWA cases. His session will provide
insights into clinical experiences with MWA in thyroid care.
Baird Medical remains committed to supporting the ongoing
advancement of minimally invasive technologies and collaborating
with healthcare professionals to explore innovative approaches in
thyroid treatment.
About Baird Medical
Baird Medical is a leading provider of minimally invasive
microwave ablation (MWA) technology, offering advanced treatment
solutions for conditions such as thyroid nodules, breast disease,
uterine fibroids, and liver cancer. A publicly traded company on
NASDAQ, Baird Medical is dedicated to enhancing patient care
through precision, efficiency, and safety in its innovative medical
devices. For more information, please visit
https://bairdmed.com/
About NASIT
The North American Society for Interventional Thyroidology
(NASIT) is the largest multidisciplinary group in the United States dedicated to the field of
interventional thyroidology. The society was established to promote
the safe integration of ablative thyroid technologies into clinical
practice while fostering a collaborative environment that supports
education and research in the field. NASIT's mission is twofold:
(1) to ensure the safe adoption of ablative technologies in thyroid
treatment and (2) to encourage interdisciplinary cooperation among
physicians specializing in interventional thyroidology.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the United States Private Securities Litigation
Reform Act of 1995. Forward-looking statements are statements that
are not historical facts and generally relate to future events or
Baird Medical's future financial or operational performance. In
some cases, you can identify forward-looking statements by
terminology such as "may," "might," "will," "should," "expect,"
"intend," "plan," "anticipate," "believe," "estimate," "predict,"
"potential," "continue," or the negative of these terms or other
similar expressions.
These forward-looking statements are subject to risks,
uncertainties, and assumptions that could cause actual results or
outcomes to differ materially from those expressed or implied.
These statements are based on estimates and assumptions that, while
considered reasonable by Baird Medical and its management, are
inherently uncertain. Risks and uncertainties may emerge over time,
and it is not possible to anticipate all potential factors that
could affect Baird Medical's business and financial
performance.
Factors that could cause actual results to differ materially
include, but are not limited to: (1) the risk that Baird Medical
may not achieve its expansion goals in the United States, China, or other markets; (2) changes in
economic, regulatory, or market conditions that impact Baird
Medical's operations; (3) the ability to realize anticipated
benefits from ongoing business initiatives or strategic
transactions; (4) regulatory developments and compliance with
applicable laws; (5) risks related to the development,
commercialization, and market acceptance of Baird Medical's
products; and (6) other risks and uncertainties detailed in Baird
Medical's filings with the SEC.
Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date they
are made. Baird Medical undertakes no obligation to update or
revise forward-looking statements, whether as a result of new
information, future events, or otherwise, except as required by
law. All forward-looking statements in this press release are
qualified in their entirety by this cautionary statement.
Contact:
Eric Huang, PR Liaison
Baird Medical Investment Holdings Ltd.
Phone: +1 (888) 508-6228
Email: ir@bairdmed.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/baird-medical-to-participate-in-nasit-2025-conference-302359444.html
SOURCE BDMD
